These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7742522)

  • 21. [ATRAC therapy].
    Miyazaki Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():628-31. PubMed ID: 25831836
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia.
    Wang ZY; Chen Z
    Lancet Oncol; 2000 Oct; 1():101-6. PubMed ID: 11905660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all-trans-retinoic acid: suppression of the leukaemic clone.
    Bashford J; Szer J; Wiley JS; Buckley M; Garson OM; Van der Weyden MB
    Br J Haematol; 1991 Oct; 79(2):331-4. PubMed ID: 1958492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia.
    Paydas S; Yavuz S; Disel U; Sahin B; Canbolat T; Tuncer I
    Leuk Lymphoma; 2003 Mar; 44(3):547-8. PubMed ID: 12688331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 28. Approaches for an explanation of the differentiating effect of all trans retinoic acid in acute promyelocytic leukemia.
    Degos L
    Leukemia; 1992 Nov; 6 Suppl 4():44-6. PubMed ID: 1434831
    [No Abstract]   [Full Text] [Related]  

  • 29. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
    Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP
    Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia.
    Polampalli S; Choughule A; Prabhash K; Amare P; Baisane C; Kabre S; Mahadik S; Shinde S; Nair R; Banavali S
    Indian J Cancer; 2011; 48(1):60-7. PubMed ID: 21248444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Trans-retinoic acid. Treatment by differentiation of acute promyelocytic leukemia].
    Castaigne S
    Soins; 1990; (538-539):24-6. PubMed ID: 2237532
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraventricular thrombosis during all-trans retinoic acid treatment in acute promyelocytic leukemia.
    Torromeo C; Latagliata R; Avvisati G; Petti MC; Mandelli F
    Leukemia; 2001 Aug; 15(8):1311-3. PubMed ID: 11480580
    [No Abstract]   [Full Text] [Related]  

  • 33. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management.
    Dombret H; Castaigne S; Fenaux P; Chomienne C; Degos L
    Leukemia; 1994; 8 Suppl 3():S73-5. PubMed ID: 7808030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of extramedullary acute promyelocytic leukemia by all-trans-retinoic acid.
    Lederman CA; Weisberger J; Seiter K; Feldman EJ
    Leuk Lymphoma; 1995 Jun; 18(1-2):189-93. PubMed ID: 8580825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral arsenic and retinoic acid for non-high-risk acute promyelocytic leukemia.
    Zhu HH; Huang XJ
    N Engl J Med; 2014 Dec; 371(23):2239-41. PubMed ID: 25470713
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. All-trans-retinoic acid: what is it good for?
    Warrell RP
    J Clin Oncol; 1992 Nov; 10(11):1659-61. PubMed ID: 1403047
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute promyelocytic leukemia: biology and treatment.
    Fenaux P; Chomienne C; Degos L
    Semin Oncol; 1997 Feb; 24(1):92-102. PubMed ID: 9045308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-trans retinoic acid--chemotherapy interactions in acute promyelocytic leukaemia.
    Roberts AW; Sheridan WP; Grigg AP
    Aust N Z J Med; 1992 Dec; 22(6):704. PubMed ID: 1489298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.